Total investments received (USD): 4.1m
Round value (USD): 4.1m
Round investors:
Novo A/S
Sound Bioventures
Company: Breye Therapeutics





Belgium
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain